P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1137-1142

  Haberl, Ines ^a   Swatonek, Helene ^a   Schaufler, Katharina ^a   Ulsperger, Ernst ^b   Wenzl, Etienne ^a   Theyer, Gerhard ^c   Hamilton, Gerhard ^a,b,d   Thalhammer, Therese ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adenocarcinoma; Chemosensitizer pretreatment; Doxorubicin; HCT 8; Multidrug resistance; P glycoprotein

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; TAMOXIFEN; VALSPODAR; VERAPAMIL; VINBLASTINE;

ARTICLE; CHEMOSENSITIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTESTINE CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031966195     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.1137     Document Type: Article

References (29)

1. Lehnert M: Clinical multidrug resistance in cancer - a multi-factorial problem. Eur J Cancer 32A: 912-920, 1996.
2. German UA: P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A: 927-944, 1996.
3. Ling V: Multidrug resistance: molecular mechanism and clinical relevance. Cancer Chemother Pharmacol 40: S3-S8, 1997.
4. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N and Fojo AT: Modulation of the expression of a multidrug resistance gene (mdrl/P-glycoprotein) by differentiating agents. J Biol Chem 264: 18031-18040, 1989.
5. Bates SE, Currier SJ, Alvarez M and Fojo AT: Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 31: 6366-6372, 1992.
6. Kang Y and Perry RR: Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. Cancer Res 54: 2952-2958, 1994.
7. Herzog CE, Tsokos M, Bates SE and Fojo AT: Increased mdrl/ P-glycoprotein expression after treatment of human coloncarcinoma cells with P-glycoprotein antagonists. J Biol Chem 268: 2946-2952, 1993.
8. Muller C, Bailly J-D, Goubin F, Lared J, Jaffrezou JP, Bordier C and Laurent G: Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. Int J Cancer 56: 749-754, 1994.
9. Gottesmann MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
10. Hunter J, Hirst BH and Simmons NL: Epithelial secretion of vinblastine by the human adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. Br J Cancer 64: 437-450, 1991.
11. Zacherl J, Hamilton G, Thalhammer T, Riegler M, Consentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Kopema T and Wenzl E: Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC833 in dependence on extracellular pH. Cancer Chemother Pharmacol 34: 125-132, 1994.
12. Thalhammer T, Stapf V, Gajdzik L and Graf J: Bile canalicular dye secretion as a model for P-glycoprotein mediated transport. Eur J Pharmacol 270: 213-220, 1994.
13. Hamada H, Hagiwara K-I, Nakajiama T and Tsuruo T: Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: efffects of verapamil, trifluoperazine and phorbol esters. Cancer Res 47: 2860-2865, 1987.
14. Sonneveld P and Wiemer E: Inhibitors of multidrug resistance. Curr Opin Oncol 9: 543-548, 1997.
15. Walther W and Stein U: Influence of cytokines on mdrl expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J Cancer Res Clin Oncol 120: 471-478, 1994.
16. Cass CE, Janowska-Wieczorek A, Lynch MA, Sheinin H, Hindenburg AA and Beck WT: Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cancer Res 49: 5798-5804, 1989.
17. Jachez B, Cianfriglia M and Loor F: Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents. Anticancer Drugs 5: 655-665, 1994.
18. O'Brian CA, Liskamp RM, Soloman DH and Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 24462-2465, 1985.
19. Fine RL, Patel J and Chabner BA: Phorbol esters induce multidrug resistance in tumor cells. Proc Natl Acad Sci USA 85: 582-586, 1988.
20. Chambers TC, McAvoy EM, Jacobs JW and Eilon G: Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679-7686, 1990.
21. Chambers TC, Zheng B and Kuo JF: Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug resistant human KB cells. Mol Pharmacol 41: 1008-1015, 1992.
22. Chambers TC, Pohl J, Raynor RLM and Kuo JF: Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 268: 4592-4595, 1993.
23. Ahmad S, Afa AR and Glazer RI: Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry 33: 10313-10318, 1994.
24. Grunicke H, Huffman J, Utz I and Überall F: Role of protein kinases in antitumor drug resistance. Ann Hematol 69: S1-S6, 1994.
25. Smith CD and Zifou JT: Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases. J Biol Chem 270: 28145-28152, 1995.
26. Ma L, Marquardt D, Takemoto L and Center MS: Analysis of P-glycoprotein phosphorylation in HL-60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593-5599, 1995.
27. Sachs CW, Safa AR, Harrison SD and Fine RL: Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J Biol Chem 270: 26639-26648, 1995.
28. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I and Gottesman MM: Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 271: 1708-1716, 1996.
29. Goodfellow HR, Sardini A, Ruetz S, Callaghan R, Gros P, McNaughton PA and Higgins CF: Protein-kinase C mediated phosphorylation does not regulate drug transport by multidrug resistance P-glycoprotein. J Biol Chem 271: 13668-13674, 1996.